Artelo Biosciences, Inc. SEC filings ARTL
Artelo Biosciences, Inc. has 465 filings in SEC EDGAR's recent list, going back to Oct 8, 2014. Its latest annual report, Form ARS, was filed on Jun 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q/A | Amended quarterly report | Aug 20, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Jan 12, 2022 | Nov 30, 2021 |
| 10-Q | Quarterly report | Jul 12, 2021 | May 31, 2021 |
| 10-Q | Quarterly report | Apr 13, 2021 | Feb 28, 2021 |
| 10-Q | Quarterly report | Jan 14, 2021 | Nov 30, 2020 |
| 10-Q | Quarterly report | Jul 13, 2020 | May 31, 2020 |
| 10-Q | Quarterly report | Apr 13, 2020 | Feb 29, 2020 |
| 10-Q | Quarterly report | Jan 14, 2020 | Nov 30, 2019 |
| 10-Q | Quarterly report | Jul 15, 2019 | May 31, 2019 |
| 10-Q | Quarterly report | Apr 15, 2019 | Feb 28, 2019 |
| 10-Q | Quarterly report | Jan 14, 2019 | Nov 30, 2018 |
| 10-Q | Quarterly report | Jul 13, 2018 | May 31, 2018 |
| 10-Q/A | Amended quarterly report | May 14, 2018 | Feb 28, 2018 |
| 10-Q/A | Amended quarterly report | May 14, 2018 | Nov 30, 2017 |
| 10-Q | Quarterly report | Apr 16, 2018 | Feb 28, 2018 |
| 10-Q/A | Amended quarterly report | Mar 21, 2018 | Nov 30, 2017 |
| 10-Q | Quarterly report | Jan 16, 2018 | Nov 30, 2017 |
| 10-Q | Quarterly report | Jul 21, 2017 | May 31, 2017 |
| 10-Q | Quarterly report | Apr 14, 2017 | Feb 28, 2017 |
| 10-Q | Quarterly report | Jan 10, 2017 | Nov 30, 2016 |
| 10-Q | Quarterly report | Jul 5, 2016 | May 31, 2016 |
| 10-Q | Quarterly report | Apr 1, 2016 | Feb 29, 2016 |
| 10-Q | Quarterly report | Jan 14, 2016 | Nov 30, 2015 |
| 10-Q | Quarterly report | Jul 15, 2015 | May 31, 2015 |
| 10-Q | Quarterly report | Apr 14, 2015 | Feb 28, 2015 |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARTL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Solana Beach, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1621221
- Former names
- REACTIVE MEDICAL INC. (until Apr 17, 2017); KNIGHT KNOX DEVELOPMENT CORP. (until Feb 6, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.